- Sequentially expressed genes in neural progenitors create neural diversity, NYU biologists find
- Exposure to low doses of BPA linked to increased risk of prostate cancer in human stem cells
- Researchers demonstrate use of stem cells to analyze causes, treatment of diabetes
- Mount Sinai researchers succeed in programming blood forming stem cells
- Truly Pluripotent Stem Cells – A Pending Breakthrough
- Stem cells reach standard for use in drug development
- Rewinding development: A step forward for stem cell research
- Scientists coax brain to regenerate cells lost in Huntington’s disease
A team of New York University biologists has found that a series of genes sequentially expressed in brain stem cells control the generation of neural diversity in visual system of fruit flies. Their results are reported in the latest issue of the journal Nature.
Exposing developing tissue to low levels of the plastic bisphenol A, commonly known as BPA, is linked to a greater incidence of prostate cancer in tissue grown from human prostate stem cells, a new study finds. The results were presented Monday, June 17, at The Endocrine Society’s 95th Annual Meeting in San Francisco.
A team from the New York Stem Cell Foundation (NYSCF) Research Institute and the Naomi Berrie Diabetes Center of Columbia University has generated patient-specific beta cells, or insulin-producing cells, that accurately reflect the features of maturity-onset diabetes of the young (MODY).
By transferring four genes into mouse fibroblast cells, researchers at the Icahn School of Medicine at Mount Sinai have produced cells that resemble hematopoietic stem cells, which produce millions of new blood cells in the human body every day. These findings provide a platform for future development of patient-specific stem/progenitor cells, and more differentiated blood products, for cell-replacement therapy.
Stem Cell Research may soon be coming into a new level of progress. A new discovery of what seems to be genuinely pluripotent stem cells coined as MUSE-AT (multilineage-differentiating stress-enduring cells, derived from adipose tissue is an imminent breakthrough in the ongoing multi-million and multi-national regenerative medicine research.
Drug development for a range of conditions could be improved with stem cell technology that helps doctors predict the safety and the effectiveness of potential treatments.
Cancer TreatmentClarifying the effect of stem cell therapy on cancer New method developed to expand blood stem cells for bone marrow transplant Protein central to cancer stem cell formation provides new potential target Ovarian cancer stem cell study puts targeted therapies within reach
Organs & BonesRewinding development: A step forward for stem cell research Stem-cell-based strategy boosts immune system in mice New technique provides human embryonic stem cells for personalized medicine NYSCF scientists create personalized bone substitutes from skin cells
Transform & RegenerateTruly Pluripotent Stem Cells – A Pending Breakthrough Recipe for large numbers of stem cells requires only one ingredient, says NIH/Pitt team IUPUI stem cell research could expand clinical use of regenerative human cells Key protein revealed as trigger for stem cell development
A natural trigger that enables stem cells to become any cell-type in the body has been discovered by scientists. Read More →